7.4: Whole Blood, Leucocyte Depleted - JPAC

JPAC Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee
  • About JPAC
  • Latest Updates
  • Document Library
  • Contact Us
Search
  • Guidelines for the Blood Transfusion Services in the UK
    • Updates
    • 1: Introduction
    • 2. Quality in blood and tissue establishments and hospital blood banks
    • 3: Care and selection of whole blood and component donors (including donors of pre-deposit autologous blood)
    • 4: Premises and quality assurance at blood donor sessions
    • 5: Collection of a blood or component donation
    • 6: Evaluation and manufacture of blood components
    • 7: Specifications for blood components
    • 8: Evaluation of novel blood components, production processes and blood packs: generic protocols
    • 9: Microbiology tests for donors and donations: general specifications for laboratory test procedures
    • 10: Investigation of suspected transfusion-transmitted infection
    • 11: Reagent manufacture
    • 12: Donation testing (red cell immunohaematology)
    • 13: Patient testing (red cell immunohaematology)
    • 14: Guidelines for the use of DNA/PCR techniques in Blood Establishments
    • 15: Molecular typing for red cell antigens
    • 16: HLA typing and HLA serology
    • 17: Granulocyte immunology
    • 18: Platelet immunology
    • 19: Tissue banking: general principles
    • 20: Tissue banking: selection of donors
    • 21: Tissue banking: tissue retrieval and processing
    • 22: Haemopoietic progenitor cells
    • 23: Specification for the uniform labelling of blood, blood components and blood donor samples
    • 24: Specification for the uniform labelling of human tissue products using ISBT 128
    • 25: Standards for electronic data interchange within the UK Blood Transfusion Services
    • 26: Specification for blood pack base labels
    • 27: Specification for labelling consumables used in therapeutic product production
    • A1: NIBSC standards available from MHRA
    • A2: ISBT 128 check character calculation
    • A3: Provisional Components
    • A4: Redundant Components
    • A5: Blood Components for Contingency Use
    • A6: Advanced Therapy Medicinal Products (ATMPs)
    • A7: Requirements for the timing of testing for HPCs
  • Donor Selection Guidelines
    • Bone Marrow and PBSC
      • A-Z Search
    • Cord Blood
      • A-Z Search
    • Geographical Disease Risk Index
      • A-Z Search
    • Tissue - Deceased Donors
      • A-Z Search
    • Tissue - Live Donors
      • A-Z Search
    • Whole Blood and Components
      • A-Z Search
    • National Helplines
  • Handbook ofTransfusion Medicine
  • TransfusionPractice
    • UK Cell Salvage Action Group
    • Consent for Blood Transfusion
      • Transfusion information for patients
      • Guidance for HealthCare Practitioners involved in this role
    • Blood Transfusion e-Learning
    • Clinical Decision-Making and Authorising Blood Component Transfusion
  • Systematic ReviewInitiative
  • UK Transfusion Committees
    • National Blood Transfusion Committee (England)
    • Scottish National Blood Transfusion Committee
    • Blood Health National Oversight Group (Wales)
    • Northern Ireland Transfusion Committee
    • UK Red Alert Plans Group
404: Not Found

We could not find the page you were trying to view.

Tag » How Many Ml In A Unit Of Blood